Literature DB >> 28209015

Boron Neutron Capture Therapy - A Literature Review.

Kavitaa Nedunchezhian1, Nalini Aswath2, Manigandan Thiruppathy3, Sarumathi Thirugnanamurthy4.   

Abstract

Boron Neutron Capture Therapy (BNCT) is a radiation science which is emerging as a hopeful tool in treating cancer, by selectively concentrating boron compounds in tumour cells and then subjecting the tumour cells to epithermal neutron beam radiation. BNCT bestows upon the nuclear reaction that occurs when Boron-10, a stable isotope, is irradiated with low-energy thermal neutrons to yield α particles (Helium-4) and recoiling lithium-7 nuclei. A large number of 10 Boron (10B) atoms have to be localized on or within neoplastic cells for BNCT to be effective, and an adequate number of thermal neutrons have to be absorbed by the 10B atoms to maintain a lethal 10B (n, α) lithium-7 reaction. The most exclusive property of BNCT is that it can deposit an immense dose gradient between the tumour cells and normal cells. BNCT integrates the fundamental focusing perception of chemotherapy and the gross anatomical localization proposition of traditional radiotherapy.

Entities:  

Keywords:  10Boron; Borocaptate sodium; Boronophenylalanine; Chemotherapy; Radiotherapy

Year:  2016        PMID: 28209015      PMCID: PMC5296588          DOI: 10.7860/JCDR/2016/19890.9024

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  30 in total

1.  Neutron capture therapy of gliomas using boron.

Authors:  L E FARR; W H SWEET; H B LOCKSLEY; J S ROBERTSON
Journal:  Trans Am Neurol Assoc       Date:  1954

2.  Neuropathologic study of fourteen cases of malignant brain tumor treated by boron-10 slow neutron capture radiation.

Authors:  A K Asbury; R G Ojemann; S L Nielsen; W H Sweet
Journal:  J Neuropathol Exp Neurol       Date:  1972-04       Impact factor: 3.685

3.  The effect of increasing exposures of the 10-B(n,alpha)7-Li reaction on the skin of man.

Authors:  J O Archambeau
Journal:  Radiology       Date:  1970-01       Impact factor: 11.105

4.  Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.

Authors:  G W Kabalka; G T Smith; J P Dyke; W S Reid; C P Longford; T G Roberts; N K Reddy; E Buonocore; K F Hübner
Journal:  J Nucl Med       Date:  1997-11       Impact factor: 10.057

Review 5.  Boron neutron capture therapy of cancer: current status and future prospects.

Authors:  Rolf F Barth; Jeffrey A Coderre; M Graça H Vicente; Thomas E Blue
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

6.  The EORTC Boron Neutron Capture Therapy (BNCT) Group: achievements and future projects.

Authors:  W Sauerwein; A Zurlo
Journal:  Eur J Cancer       Date:  2002-03       Impact factor: 9.162

7.  Boron Neutron Capture Therapy for glioblastoma multiforme: advantage of prolonged infusion of BPA-f.

Authors:  K Sköld; B H-Stenstam; A Z Diaz; V Giusti; L Pellettieri; J W Hopewell
Journal:  Acta Neurol Scand       Date:  2009-11-26       Impact factor: 3.209

8.  Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden.

Authors:  Jacek Capala; Britta H Stenstam; Kurt Sköld; Per Munck af Rosenschöld; Valerio Giusti; Charlotta Persson; Eva Wallin; Arne Brun; Lars Franzen; Jörgen Carlsson; Leif Salford; Crister Ceberg; Bertil Persson; Luigi Pellettieri; Roger Henriksson
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

Review 9.  Boron neutron capture therapy for cancer. Realities and prospects.

Authors:  R F Barth; A H Soloway; R G Fairchild; R M Brugger
Journal:  Cancer       Date:  1992-12-15       Impact factor: 6.860

10.  First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome.

Authors:  S J González; M R Bonomi; G A Santa Cruz; H R Blaumann; O A Calzetta Larrieu; P Menéndez; R Jiménez Rebagliati; J Longhino; D B Feld; M A Dagrosa; C Argerich; S G Castiglia; D A Batistoni; S J Liberman; B M C Roth
Journal:  Appl Radiat Isot       Date:  2004-11       Impact factor: 1.513

View more
  19 in total

1.  Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model.

Authors:  Marcela A Garabalino; Nahuel Olaiz; Agustina Portu; Gisela Saint Martin; Silvia I Thorp; Emiliano C C Pozzi; Paula Curotto; María E Itoiz; Andrea Monti Hughes; Lucas L Colombo; David W Nigg; Verónica A Trivillin; Guillermo Marshall; Amanda E Schwint
Journal:  Radiat Environ Biophys       Date:  2019-05-23       Impact factor: 1.925

2.  Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.

Authors:  Sinan Wang; Charles Blaha; Raquel Santos; Tony Huynh; Thomas R Hayes; Denis R Beckford-Vera; Joseph E Blecha; Andrew S Hong; Miko Fogarty; Thomas A Hope; David R Raleigh; David M Wilson; Michael J Evans; Henry F VanBrocklin; Tomoko Ozawa; Robert R Flavell
Journal:  Mol Pharm       Date:  2019-08-16       Impact factor: 4.939

Review 3.  Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.

Authors:  Jörgen Elgqvist
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

Review 4.  CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.

Authors:  María Auxiliadora Olivares-Urbano; Carmen Griñán-Lisón; Juan Antonio Marchal; María Isabel Núñez
Journal:  Cells       Date:  2020-07-09       Impact factor: 6.600

5.  Characterization of Reactive Organometallic Species via MicroED.

Authors:  Christopher G Jones; Matthew Asay; Lee Joon Kim; Jack F Kleinsasser; Ambarneil Saha; Tyler J Fulton; Kevin R Berkley; Duilio Cascio; Andrey G Malyutin; Matthew P Conley; Brian M Stoltz; Vincent Lavallo; José A Rodríguez; Hosea M Nelson
Journal:  ACS Cent Sci       Date:  2019-09-06       Impact factor: 14.553

6.  Biomedical Research Programs at Present and Future High-Energy Particle Accelerators.

Authors:  Vincenzo Patera; Yolanda Prezado; Faical Azaiez; Giuseppe Battistoni; Diego Bettoni; Sytze Brandenburg; Aleksandr Bugay; Giacomo Cuttone; Denis Dauvergne; Gilles de France; Christian Graeff; Thomas Haberer; Taku Inaniwa; Sebastien Incerti; Elena Nasonova; Alahari Navin; Marco Pullia; Sandro Rossi; Charlot Vandevoorde; Marco Durante
Journal:  Front Phys       Date:  2020-10-16

7.  Construction of Boronophenylalanine-Loaded Biodegradable Periodic Mesoporous Organosilica Nanoparticles for BNCT Cancer Therapy.

Authors:  Fuyuhiko Tamanoi; Shanmugavel Chinnathambi; Mathilde Laird; Aoi Komatsu; Albane Birault; Takushi Takata; Tan Le-Hoang Doan; Ngoc Xuan Dat Mai; Arthur Raitano; Kendall Morrison; Minoru Suzuki; Kotaro Matsumoto
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

8.  Boron nitride nanotubes as containers for targeted drug delivery of doxorubicin.

Authors:  Marjan A Nejad; Philipp Umstätter; Herbert M Urbassek
Journal:  J Mol Model       Date:  2020-02-08       Impact factor: 2.172

Review 9.  Precision Medicine in Pediatric Neurooncology: A Review.

Authors:  Aaron Y Mochizuki; Isaura M Frost; Melina B Mastrodimos; Ashley S Plant; Anthony C Wang; Theodore B Moore; Robert M Prins; Paul S Weiss; Steven J Jonas
Journal:  ACS Chem Neurosci       Date:  2017-12-27       Impact factor: 4.418

Review 10.  Boron neutron capture therapy: Current status and future perspectives.

Authors:  Mayya Alexandrovna Dymova; Sergey Yurjevich Taskaev; Vladimir Alexandrovich Richter; Elena Vladimirovna Kuligina
Journal:  Cancer Commun (Lond)       Date:  2020-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.